Cymbiotika Lands in Ulta Just Months After Launching in Target

Cymbiotika Lands in Ulta Just Months After Launching in Target

Modern Retail
Modern RetailMar 13, 2026

Why It Matters

The move underscores the mainstreaming of premium wellness supplements within beauty retail, diversifying revenue streams and accelerating growth for both Cymbiotika and its retail partners.

Key Takeaways

  • Ulta rollout adds 1,000+ stores nationwide
  • Retail goal: 60% revenue, down from 80% DTC
  • $25M seed funding follows $150M sales milestone
  • Influencer and in‑store sampling drive consumer education
  • Celebrity investors include The Weeknd and Post Malone

Pulse Analysis

Cymbiotika’s entry into Ulta reflects a broader industry trend where wellness brands are crossing over into beauty aisles to capture health‑conscious shoppers. The company’s liposomal delivery system promises higher nutrient absorption, a claim that resonates with consumers seeking functional beauty products. By debuting four flagship items—ranging from NAD boosters to magnesium gels—Cymbiotika positions itself as a convenient, on‑the‑go solution, aligning with Ulta’s emphasis on experiential retail and rapid product discovery.

The partnership leverages Ulta’s robust in‑store activation platform, which saw over 20,000 events last year, to educate shoppers through sampling stations and influencer‑led demos. This hands‑on approach addresses a key hurdle for supplement startups: consumer understanding of novel formats. By offering starter packs in Target’s value‑priced sections and now scaling similar tactics at Ulta, Cymbiotika creates low‑risk entry points that encourage trial and repeat purchase, a strategy that could reshape how beauty retailers curate wellness assortments.

Financially, the brand’s $25 million seed round—raised after hitting $150 million in revenue—provides the runway to support inventory, fulfillment, and marketing investments required for nationwide distribution. Celebrity backers such as The Weeknd and Post Malone add cultural cachet, amplifying reach through social channels. As Cymbiotika targets a 60% retail revenue mix, its success will likely spur other supplement innovators to pursue similar omnichannel pathways, intensifying competition in both the beauty and broader health‑and‑wellness markets.

Cymbiotika lands in Ulta just months after launching in Target

Comments

Want to join the conversation?

Loading comments...